Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1539558

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1539558

Mental Health Market Size, Share, Growth Analysis, By Age Group, By Services, By Setting, By Region - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Mental Health Market size was valued at USD 399.61 billion in 2022 and is poised to grow from USD 413.60 billion in 2023 to USD 544.63 billion by 2031, at a CAGR of 3.5% during the forecast period (2024-2031).

The Mental Health Market encompasses a wide range of products and services designed to prevent, treat, and manage mental health disorders. This market includes pharmaceuticals, psychotherapy, digital health solutions, and other therapeutic interventions aimed at providing effective and accessible treatment options for those facing mental health challenges. The market's primary goal is to alleviate the burden of mental illness on individuals, families, and society as a whole. The increasing global prevalence of mental health disorders is a key driver of this market's growth, along with growing awareness and acceptance of mental health issues. Technological advancements and research have also paved the way for innovative treatment options, including digital health solutions. However, the mental health market faces significant challenges, particularly the stigma surrounding mental illness, which can deter individuals from seeking treatment. The COVID-19 pandemic has exacerbated existing mental health issues and introduced new ones, such as increased stress and social isolation. While digital mental health solutions offer benefits, they also raise concerns regarding privacy and effectiveness. Additionally, emerging issues like youth mental health, work-related stress, and the impact of climate change on mental health have become increasingly important. These challenges underscore the need for continued innovation and enhanced support for mental health initiatives.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Mental Health market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mental Health Market Segmental Analysis

The Mental Health Market is segmented based on Application, Screening Method, Technology, Age Group, Setting and region. Based on Application, the market is segmented into Physiological Disorder(Depression, Anxiety, Post-Traumatic Stress Disorder (PTSD), Bipolar Disorder, Eating Disorder, Substance Abuse, Other Physiological Disorders), Psychiatric Disorders (Schizophrenia, Psychotic Disorder, Dissociative Disorder, Obsessive Compulsive Disorder, Dissociative Disorder, Attention Deficit Hyperactivity Disorder (ADHD), Other Psychiatric Disorders), Behavioral Disorders(Self-Harm, Aggression, Sleep Disorder, Social Withdrawal, Dissociative Disorder, Hyperactivity, Other Behavioral Disorders), Cognitive Disorders(Cognitive Impairment, Dementia, Alzheimer's Disease, Other Cognitive Disorders), By Technology the market is segmented into Self Screening Mental Health Apps, Telehealth And virtual Care Solutions, Continuous Monitoring Wearable Devices, AI Based Screening Tools, Remote Mental Health Platforms , By Age Group, the market is segmented into Children And Adolescents, Adults, Seniors, By Setting the market is segmented into Clinical Setting Educational Institutions Workspace Slash Corporate Programs Online Platforms Other Settings, By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Mental Health Market

The increasing prevalence of mental health disorders, influenced by high-stress lifestyles, the lingering effects of COVID-19, and improved diagnostic methods, is driving the demand for mental health services. As public awareness campaigns gain momentum and stigma surrounding mental health diminishes, more individuals are encouraged to seek the help they need, contributing to the market's expansion. This growing recognition of mental health issues, combined with enhanced diagnostic capabilities, is leading to a surge in demand for mental health services. The positive shift in public perception, supported by awareness initiatives, is making it easier for people to seek treatment, thereby accelerating the growth of the mental health market.

Restraints in the Global Mental Health Market

The stigma surrounding mental illness remains a significant barrier to the utilization of mental health screening tools and resources. Despite ongoing efforts to reduce stigma and raise awareness, social misconceptions and negative attitudes about mental health persist, discouraging individuals from seeking help and using screening tools. A 2023 study by NAMI revealed that 44% of Americans with mental health conditions reported experiencing discrimination due to their diagnosis. Fear of judgment, unfair treatment, or negative consequences often leads individuals to delay screening and treatment, which can worsen symptoms and complicate the management of mental health conditions.

Market Trends of the Global Mental Health Market

Telemedicine has become a significant trend in the mental health market, offering remote services like teletherapy and telepsychiatry that can be accessed from anywhere via smartphones or computers. This approach enhances accessibility and convenience, especially for patients in rural or remote areas, and can also be more cost-effective than traditional in-person care. Companies like Teladoc Health and Amwell are at the forefront of providing these telemedicine services, making mental health support more widely available.

Product Code: SQMIG35A2233

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors of The Market
  • Degree Of Competition
  • Top Investment Pockets
  • Market Attractive Index
  • Ecosystem Mapping
  • Pricing analysis
  • Value chain analysis
  • Regulatory Analysis
  • Technology Analysis
  • Ecosystem analysis
  • Patent Analysis

Mental Health Market by Application

  • Physiological Disorder
    • Depression
    • Anxiety
    • Post-Traumatic Stress Disorder (PTSD)
    • Bipolar Disorder
    • Eating Disorder
    • Substance Abuse
    • Other Physiological Disorders
  • Psychiatric Disorders
    • Schizophrenia
    • Psychotic Disorder
    • Dissociative Disorder
    • Obsessive Compulsive Disorder
    • Dissociative Disorder
    • Attention Deficit Hyperactivity Disorder (ADHD)
    • Other Psychiatric Disorders
  • Behavioral Disorders
    • Self-Harm
    • Aggression
    • Sleep Disorder
    • Social Withdrawal
    • Dissociative Disorder
    • Hyperactivity
    • Other Behavioral Disorders
  • Cognitive Disorders
    • Cognitive Impairment
    • Dementia
    • Alzheimer's Disease
    • Other Cognitive Disorders

Mental Health Market by Technology

  • Self-Screening Mental Health Apps
  • Telehealth And virtual Care Solutions
  • Continuous Monitoring Wearable Devices
  • AI Based Screening Tools
  • Remote Mental Health Platforms

Mental Health Market by Age Group

  • Children And Adolescents
  • Adults
  • Seniors

Mental Health Market by Setting

  • Clinical Setting
  • Educational Institutions
  • Workspace/Corporate Programs
  • Online Platforms
  • Other Settings

Mental Health Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Pfizer Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eli Lilly and Company (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bristol-Myers Squibb (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AstraZeneca (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck & Co., Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takeda Pharmaceutical Company Limited (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Otsuka Holdings Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis International AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi S.A. (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lundbeck A/S (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teva Pharmaceutical Industries Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AbbVie Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boehringer Ingelheim International GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • H. Lundbeck A/S (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sun Pharmaceutical Industries Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alkermes plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amgen Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gilead Sciences, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hikma Pharmaceuticals PLC (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jazz Pharmaceuticals plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!